Mycophenolate Mofetil 250mg Tablets

Mycophenolate Mofetil 250mg is an antimetabolite immunosuppressant used with other anti-rejection medicines after organ transplantation. It limits the immune response against the transplanted organ rather than treating an established infection.
Swallow the tablets whole on an empty stomach, usually one hour before or two hours after food, unless the transplant team specifies a consistent alternative. Do not crush or break them; avoid contact with damaged tablets.
Mycophenolate mofetil is converted to mycophenolic acid, which inhibits IMP dehydrogenase and limits guanine-nucleotide synthesis in activated lymphocytes.
Diarrhoea, vomiting, abdominal discomfort and reduced white-cell counts are common concerns; infections can occur more readily.
Exposure during pregnancy can cause miscarriage and severe birth defects. Pregnancy testing, effective contraception, blood counts and infection surveillance are essential parts of treatment. Women who can become pregnant require effective contraception during treatment and for six weeks after stopping; the transplant team plans any pregnancy-related change before treatment is interrupted.
Provides an additional anti-rejection mechanism alongside the other components of transplant treatment.
No. Different formulations have different strengths and absorption characteristics; the transplant team must manage a switch.
Contact the transplant team; dehydration, infection and altered medicine exposure need assessment.
No. Crushing exposes the active medicine and may affect administration. The transplant team can arrange an appropriate alternative formulation for swallowing difficulty.
Treatment can suppress white cells and other blood cells, increasing infection or bleeding risk.
Magnesium- or aluminium-containing antacids can reduce absorption; obtain a separation schedule.
It requires advance specialist planning and an alternative regimen where appropriate; do not stop anti-rejection treatment yourself.
No. Rejection prevention remains necessary even without symptoms.
They are generally avoided during immunosuppressive treatment, and vaccine responses may be reduced.
Antimetabolite: a medicine that interferes with cellular building blocks. Leucopenia: a reduced white-blood-cell count. Teratogenic: capable of causing birth defects.; AR: Mycophenolate Mofetil 250mg أقراص; FR: Mycophenolate Mofetil 250mg comprimés; PT: Mycophenolate Mofetil 250mg comprimidos; ES: Mycophenolate Mofetil 250mg comprimidos; RU: Mycophenolate Mofetil 250mg таблетки; ID: Mycophenolate Mofetil 250mg tablet; VI: Mycophenolate Mofetil 250mg viên nén; MS: Mycophenolate Mofetil 250mg tablet; TL: Mycophenolate Mofetil 250mg tableta; ZH-SG: Mycophenolate Mofetil 250mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Mycophenolate Mofetil 250mg Tablets under Transplant Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Mycophenolate Mofetil 250mg Tablets